TLPH

Talphera (TLPH)

About Talphera (TLPH)

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes Nafamostat, LTX-608, and Niyad. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Details

Daily high

$1.10

Daily low

$0.97

Price at open

$1.09

52 Week High

$1.57

52 Week Low

$0.38

Market cap

56.6M

Dividend yield

0.00%

Volume

3,433

Avg. volume

194,436

P/E ratio

-3.62

Talphera News